SP
Sea Pharmaceuticals, LLC
SEC filingPharmaceuticals · Cambridge, MA
Amount raised$71Ksold at filing
Total offering$1.7M$1.7M still open
Investors in the raise7count reported to the SEC
FiledMay 20, 2026first sale Jul 17, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Mark G. CurrieDirector
Shaker J. SadasivamDirector
James P. PearsonExecutive Officer, Director
Nabil J. ElkouhDirector
Michael J. HigginsDirector
Walter Kendall BrownDirector
Eric R OlsonDirector
Executive officers, directors and promoters as listed on the Form D.